Cargando…

Does ‘super-responder’ patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center

BACKGROUND: Whether cardiac resynchronization therapy super-responders (CRT-SRs) still have indications for neuro-hormonal antagonists or not remains uninvestigated. METHODS: We reviewed clinical data from 376 patients who underwent CRT implantation in Fuwai Hospital from 2009 to 2015 and followed u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yi-Ran, Hua, Wei, Jin, Han, Gu, Min, Fan, Xiao-Han, Niu, Hong-Xia, Ding, Li-Gang, Wang, Jing, Zhang, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500568/ https://www.ncbi.nlm.nih.gov/pubmed/31080467 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.03.015

Ejemplares similares

Cardiac electrical and mechanical synchrony of super-responders to cardiac resynchronization therapy
por: Li, Ke-Bei, et al.
Publicado: (2020)

Contractile reserve assessed by dobutamine test identifies super-responders to cardiac resynchronization therapy
por: Vukajlovic, Dejan, et al.
Publicado: (2014)

A Predictive Model for Super-Response to Cardiac Resynchronization Therapy: The QQ-LAE Score
por: Liu, Xi, et al.
Publicado: (2020)

Predictors of super-response to cardiac resynchronization therapy: the significance of heart failure medication, pre-implant left ventricular geometry and high percentage of biventricular pacing
por: Jin, Han, et al.
Publicado: (2017)

Incidence and predictors of super-response to cardiac resynchronization therapy
por: Rohit, Manoj Kumar, et al.
Publicado: (2019)

Pacing interventions in non-responders to cardiac resynchronization therapy
por: Wijesuriya, Nadeev, et al.
Publicado: (2023)

Predictors of non-response to cardiac resynchronization therapy implantation in patients with class I indications: the markedly dilated left ventricular end-diastolic dimension and the presence of fragmented QRS
por: Hu, Yi-Ran, et al.
Publicado: (2019)

Echocardiographic assessment of right ventricular function in responders and non-responders to cardiac resynchronization therapy
por: Kusiak, Aleksander, et al.
Publicado: (2015)

Cardiac resynchronization therapy non-responder to responder conversion rate in the MORE-CRT MPP trial
por: Leclercq, Christophe, et al.
Publicado: (2023)

Change in indication for cardiac resynchronization therapy?
por: Lawin, Dennis, et al.
Publicado: (2019)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
por: Ashina, Sait, et al.
Publicado: (2023)

Finding Cardiac Resynchronization Therapy Responders: Postprocedural QRS-T Morphologies Matter
por: Kim, Min, et al.
Publicado: (2020)

Radiotherapy in Current Neuro-Oncology: There Is Still Much to Reveal
por: Ferini, Gianluca, et al.
Publicado: (2021)

Improvement in quality of life with sacubitril/valsartan in cardiac resynchronization non-responders: The RESINA (RESynchronization plus an Inhibitor of Neprilysin/Angiotensin) registry
por: Campal, José Manuel Rubio, et al.
Publicado: (2021)

Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?
por: Gahrton, Gösta, et al.
Publicado: (2020)

Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis?
por: Eun, Chang Soo, et al.
Publicado: (2015)

Cardiac resynchronization therapy improved the clinical outcomes in pacemaker patients upgraded to biventricular device
por: Jin, Han, et al.
Publicado: (2017)

Does the “delayed start” protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? a randomized clinical trial
por: Ashrafi, Mahnaz, et al.
Publicado: (2018)

Effects of letrozole co-treatment on the cumulative live-birth rate among normal responders in gonadotropin-releasing hormone antagonist cycles
por: Zhang, Shuyi, et al.
Publicado: (2022)

Successful ‘quadrangular' pacing in a non-responder patient to cardiac resynchronization therapy
por: Clementy, Nicolas, et al.
Publicado: (2011)

Narrower QRS may be enough to respond to cardiac resynchronization therapy in lightweight patients
por: Nakai, Toshiko, et al.
Publicado: (2019)

Does the surgeon still have a role to play in the diagnosis and management of lymphomas?
por: Morris-Stiff, Gareth, et al.
Publicado: (2008)

Delorme's Procedure for Complete Rectal Prolapse: Does It Still Have It's Own Role?
por: Lee, Sooho, et al.
Publicado: (2012)

Does thrombo-aspiration still have a place in the treatment of myocardial infarction?
por: Schiele, François, et al.
Publicado: (2016)

Does radiotherapy still have a role in unresected biliary tract cancer?
por: Pollom, Erqi L., et al.
Publicado: (2016)

Role of sCD40L in the prediction of super-response to cardiac resynchronization therapy
por: Pujol, C., et al.
Publicado: (2021)

Incremental Value of Speckle Tracking Echocardiography to Predict Cardiac Resynchronization Therapy (CRT) Responders
por: Seo, Yoshihiro, et al.
Publicado: (2016)

Patient-specific heart simulation can identify non-responders to cardiac resynchronization therapy
por: Isotani, Akihiro, et al.
Publicado: (2020)

Mechanical Dyssynchrony Combined with Septal Scarring Reliably Identifies Responders to Cardiac Resynchronization Therapy
por: Duchenne, Jürgen, et al.
Publicado: (2023)

Identifying “super responders” in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2017)

Cardiac resynchronization therapy using left ventricular septal pacing: An alternative to biventricular pacing?
por: Gu, Min, et al.
Publicado: (2019)

Strain-time curve analysis by speckle tracking echocardiography in cardiac resynchronization therapy: Insight into the pathophysiology of responders vs. non-responders
por: To, Andrew C. Y., et al.
Publicado: (2016)

The 15-Year Evolution of the Thoracoscopic Anterior Release: Does It Still Have a Role?
por: Arunakul, Rattalerk, et al.
Publicado: (2015)

Evidence of scar tissue: contra-indication to cardiac resynchronization therapy?
por: van der Wall, E. E., et al.
Publicado: (2010)

Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy
por: Magne, Julien, et al.
Publicado: (2009)

Evaluation of Left Ventricular Endocardial Cardiac Resynchronization Therapy in a Non-responder with Ventricular Arrhythmias
por: Mafi Rad, Masih, et al.
Publicado: (2014)

Reduced T wave alternans in heart failure responders to cardiac resynchronization therapy: Evidence of electrical remodeling
por: Nayyar, Sachin, et al.
Publicado: (2018)

Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial
por: Brugada, Josep, et al.
Publicado: (2017)

The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non‐responders: a retrospective analysis
por: Chun, Kyeong‐Hyeon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vhq4qar3q4qbcspinqm0gcr3kc